icubed consulting Revenue and Competitors

Brisbane, Australia

Location

N/A

Total Funding

Construction

Industry

Estimated Revenue & Valuation

  • icubed consulting's estimated annual revenue is currently $13.6M per year.(i)
  • icubed consulting's estimated revenue per employee is $261,000

Employee Data

  • icubed consulting has 52 Employees.(i)
  • icubed consulting grew their employee count by 4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$33.4M115-21%N/AN/A
#2
$45.3M142-6%N/AN/A
#3
$219.7M60619%N/AN/A
#4
$25.2M87-27%N/AN/A
#5
$63.5M199-4%N/AN/A
#6
$38.3M13225%N/AN/A
#7
$31.6M8224%N/AN/A
#8
$47.9M15018%N/AN/A
#9
$152.6M421-6%N/AN/A
#10
$28.4M7733%N/AN/A
Add Company

icubed consulting is an international multi-disciplinary development consultancy based in Brisbane, Australia. Unlimited by geographic boundaries, icubed consulting is well placed to lead projects of various sizes from inception to post construction evaluation. We provide professional consultancy services to a number of industry sectors including: Commercial Offices, Community, Defence/Government, Energy, Land Development, Manufacturing, Mining, Residential, Retail and Warehousing.

keywords:N/A

N/A

Total Funding

52

Number of Employees

$13.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

icubed consulting's People

NameTitleEmail/Phone
1
Principal Consultant
2
Principal Structural Engineer
3
Associate / Senior Design Manager - Civil
4
consultant
5
Principal Civil Engineer
6
Civil Designer / Operations Manager
7
Senior Structural Engineer
8
Senior Design Manager - Renewables
9
Accountant
10
Civil Engineer

icubed consulting News

2022-02-22 - News: Starting a Ketamine Clinic: Another Option for EPs ...

About Depression. Ketamine was invented in 1962 by Calvin Stevens, PhD, while consulting for Parke-Davis Research Laboratory. It was approved by the FDA in 1970...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.3M5253%N/A
#2
$16.5M52-2%N/A
#3
$11.5M52-28%N/A
#4
N/A52189%N/A
#5
$7.5M5218%N/A